Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Y-mAbs Therapeutics	TG Therapeutics	Dicerna Pharmaceuticals	BELLUS Health	Intra-Cellular Therapies
Symbol	NASDAQ:YMAB	NASDAQ:TGTX	NASDAQ:DRNA	OTCMKTS:BLUSF	NASDAQ:ITCI
Price Information
Current Price	$30.47	$13.92	$20.31	N/A	$22.20
52 Week Range	Buy	Buy	Buy	N/A	Buy
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	N/A	Buy
Consensus Price Target	$39.50	$17.67	$31.57	N/A	$37.75
% Upside from Price Target	29.64% upside	26.92% upside	55.45% upside	N/A	70.05% upside
Trade Information
Market Cap	$1.23 billion	$1.40 billion	$1.40 billion	$1.69 billion	$1.27 billion
Beta	1.13	2.55	2.63	1.55	2.09
Average Volume	141,377	1,508,617	579,216	61,933	908,880
Sales & Book Value
Annual Revenue	N/A	$150,000.00	$6.18 million	$30,000.00	$250,000.00
Price / Sales	N/A	9,239.17	224.89	0.00	4,921.30
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$4.11 per share	$0.29 per share	$3.20 per share	$0.25 per share	$5.81 per share
Price / Book	N/A	48.00	6.35	0.00	3.82
Profitability
Net Income	$-43,270,000.00	$-173,480,000.00	$-88,850,000.00	$-7,010,000.00	$-155,130,000.00
EPS	($1.50)	N/A	($1.20)	N/A	($2.84)
Trailing P/E Ratio	N/A	0.00	N/A	0.00	N/A
Forward P/E Ratio	N/A	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-123,130.93%	-541.24%	-49,910.34%	N/A
Return on Equity (ROE)	-62.52%	-2,411.79%	-58.92%	-48.37%	-54.27%
Return on Assets (ROA)	-55.17%	-184.64%	-26.67%	-45.25%	-45.84%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.02%	2.77%	N/A	N/A	0.09%
Current Ratio	7.12%	1.00%	2.68%	13.87%	7.77%
Quick Ratio	7.12%	1.00%	2.68%	13.87%	7.77%
Ownership Information
Institutional Ownership Percentage	48.60%	58.40%	84.03%	N/A	68.24%
Insider Ownership Percentage	38.40%	14.20%	21.28%	24.17%	18.20%
Miscellaneous
Employees	32	105	78	10	73
Shares Outstanding	39.73 million	99.56 million	68.43 million	159.12 million	55.42 million
Next Earnings Date	3/27/2020 (Estimated)	3/3/2020 (Estimated)	2/27/2020 (Confirmed)	N/A	3/2/2020 (Confirmed)
Optionable	Not Optionable	Optionable	Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources